Lauren Hay

Lauren Hay (Dorsey) has held various key roles in the healthcare and pharmaceutical industry. Lauren began their career as a Senior Associate at Triage Consulting Group, moving on to become a Senior Consultant at The Frankel Group. Lauren then served as Vice President at DRI Capital before becoming Managing Director at Hay Advisory Corporation. Lauren is currently the President of the Board of Directors at Hemophilia Council of California and the Vice President of Strategic Planning & Investment Analytics at Ligand Pharmaceuticals.

Lauren Hay (Dorsey) obtained a BA in Human Biology from Stanford University in 2001. Lauren then pursued an MBA in Health Care from The Wharton School, completing their studies in 2007.